Back to search

University of Ioannina

Defining the mechanism of action of CHUK/ΙΚΚα kinase and additional lung-specific protein kinases in lung cancer

Abstract

dc:description

Lung cancer is the leading cause of cancer deaths worldwide and the second most common type of cancer. Despite the development of new therapies, such as immunotherapies and KRAS inhibitors, the survival rates remain low. Lung cancer is histologically divided into small- (SCLC) and non-small cell lung cancer (NSCLC). The most common type of NSCLC is lung adenocarcinoma (LUAD), which makes up to 70% of the cases. Several signalling pathways are dysregulated in LUAD, including the canonical and non-canonical NF-κB pathways. The NF-κB signalling pathways are the main regulators of inflammation, and their aberrant activation in cancer promotes cell survival, cell proliferation, migration and angiogenesis. The upstream effector of the pathway, IKKα has pleiotropic effects in cancer acting as a tumour promoter or a tumour suppressor, in a tissue specific way. NSCLC often confers loss or downregulation of tumour suppressor kinases, including LKB1, LATS1/2 and IKKα. Previous research has shown that IKKα is a tumour suppressor in lung adenocarcinoma, where IKKα ablation results in decreased cell senescence and promotes a highly immunosuppressive TME. In addition, IKKα ablation promotes the activation of the hypoxia factor HIF-1α, and its target genes, facilitating carcinogenesis under the in vivo hypoxic conditions.The aim of this study was to identify novel roles of IKKα and characterise their mechanisms accounting for IKKα’s tumour suppressor activity in lung cancer. To accomplish this, we first employed a co-immunoprecipitation mass spectrometry analysis, to determine the IKKα protein interactome in LUAD cells. This analysis identified several novel protein partners, including splicing factors, mRNA transport and mRNA surveillance proteins. We focused our next experiments on the interaction between IKKα and the ATP-dependent RNA helicase eIF4A3. eIF4A3 is a core component of the Exon Junction Complex that regulates RNA splicing, mRNA transport to the nucleus and nonsense-mediated mRNA decay. eIF4A3 is often found elevated in cancer and facilities carcinogenesis through the regulation of RNA splicing, ribosome biogenesis and autophagy. IKKα mainly interacts with eIF4A3 in the nucleus, while this interaction is independent of its kinase function. In addition, an in vitro kinase assay showed that IKKα does not phosphorylate eIF4A3. Since IKKα was found to interact with multiple splicing factors, deep RNA-sequencing was performed to study the alternative splicing in IKKα depleted cell lines. The analysis identified global isoform expression changes with intron retention being more prominent, as well as an enrichment in ribosomal subunit alternative isoforms. Cancer progression is characterised by the dysregulation of alternative splicing, further promoting the hallmarks of cancer by silencing the expression of tumour suppressor genes or by enhancing the expression or function of tumour promoters. Novel transcripts were also identified that could serve as neoantigens and be targeted for therapy.eIF4A3 also regulates ribosome biogenesis, which is often upregulated in cancer to supplement the increased need for protein synthesis and cell proliferation. We performed various ribosome biogenesis assays to study the role of IKKα in the different processes. Dysregulation of rRNA transcription and processing was found in IKKαKO cells, while global translation was elevated in these cell lines. Under nucleolar stress, IKKα depleted cells had reduced p53 and p21 activation. Furthermore, we found IKKαKO cells to be more resistant to cell death upon treatment with chemotherapeutic drugs. Finally, our whole proteomics analysis of IKKαKO cells revealed an upregulation in many metabolic pathways and the glutathione pathway, while there was a downregulation in proteins involved in RNA splicing, ribosome and rRNA processing. Overall, we identified novel protein interactors of IKKα in LUAD cell lines, that play a role in splicing and mRNA metabolism. Through these interactions, IKKα regulates alternative splicing of target genes, while it also affects ribosome biogenesis and translation. Through these functions, IKKα may play a role in protecting LUAD cells from chemotherapy resistance, acting as a tumour suppressor in lung cancer. Therefore, these findings support a novel function of IKKα in RNA splicing that can affect gene expression and protein function.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Besta, Simoni
  • Μπέστα, Σιμώνη

Subjects

dc:subject × 20

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57816

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Besta, Simoni; Μπέστα, Σιμώνη. Defining the mechanism of action of CHUK/ΙΚΚα kinase and additional lung-specific protein kinases in lung cancer. University of Ioannina, 2024. http://hdl.handle.net/10442/hedi/57816